King, Madeleine T. http://orcid.org/0000-0001-7192-2887
Revicki, D. A. http://orcid.org/0000-0001-6780-0019
Norman, R. http://orcid.org/0000-0002-3112-3893
Müller, F. http://orcid.org/0000-0002-0412-7469
Viney, R.C. http://orcid.org/0000-0002-0039-9635
Pickard, A. S. http://orcid.org/0000-0001-5645-7091
Cella, D. http://orcid.org/0000-0002-9881-4541
Shaw, J. W.
Aaronson, Neil
Brazier, John
Cella, David
Costa, Daniel
Fayers, Peter
Grimison, Peter
Janda, Monika
Kemmler, Georg
King, Madeleine T.
Luo, Nan
McTaggart-Cowan, Helen
Mercieca-Bebber, Rebecca
Norman, Richard
Revicki, Dennis
Peacock, Stuart
Pickard, Simon
Rowen, Donna
Velikova, Galina
Viney, Rosalie
Street, Deborah
Young, Tracey
Tait, Margaret-Ann
,
Funding for this research was provided by:
National Health and Medical Research Council (PG632662)
Bristol-Myers Squibb (EVA-20314-001, EVA-20314-001)
Article History
Accepted: 11 October 2023
First Online: 7 December 2023
Declarations
:
: This study was funded by Bristol Myers Squibb via a consultant agreement with Evidera (EVA-20314-001). The development of the FACT-8D descriptive system and valuation methodology was funded by an Australian National Health and Medical Research Council Project Grant (PG632662).
: DC is president of FACIT.org, which owns and distributes the FACT and FACIT questionnaires. FM reported personal fees from Evidera during the conduct of the study. SP does healthcare consulting with Second City Outcomes Research and Maths in Health. JS reports being an employee and shareholder of Bristol Myers Squibb. MK and RN report grants from Bristol Myers Squibb via Evidera during the conduction of the study. At the time of submission of this paper, RV, RN, SP and JS were members of the EuroQol Group; RV and JS were members of the EuroQol Group’s Scientific Executive; and RV chaired the Scientific Executive.
: The funder had no role in the design and conduction of the study; collection, management, analysis, and interpretation of the data; or preparation and decision to submit the manuscript for publication. The funder did review the final manuscript and approved it for publication with no substantive changes required.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: This research was conceived, designed and conducted by the Multi-Attribute Utility in Cancer (MAUCa) Consortium; the University of Sydney Human Research Ethics Committee approved the MAUCa Consortium’s program of research (No. 13207). The US valuation study was deemed exempt from US Institutional Review Board (IRB) by the Advarra IRB (CA209-466C, Pro00032061).
: Not applicable.
: Not applicable.
: Not applicable.
: MK, DC, RN, SP, DR and RV contributed towards the study concept and design; MK and RN contributed towards acquisition of data; MK, DC, FM, RN, SP, DR, JS and RV contributed towards analysis and interpretation of data; MK, DR, RN and JS contributed towards drafting of the manuscript; MK, DC, FM, RN, SP, JS and RV provided critical revision of paper for important intellectual content; RN conducted statistical analysis; MK and JS contributed towards obtaining funding; FM provided administrative, technical or logistic support; MK provided overall study supervision. DR was unable to approve the final version for submission, as he died prior to submission; his family approved his inclusion as an author.